Cogrx
2007
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$4.06M
LATEST DEAL AMOUNT
29
INVESTORS
Description
Developer of small molecule therapeutics designed to offer treatment of toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other neuro-degenerative diseases of the human brain. The company's uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system, enabling patients to recover faster through advanced medical technology.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 2403 Sidney Street
- Pittsburgh, PA 15203
- United States
+1 (412) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cogrx’s full profile, request a free trial.
Cogrx Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 27-Nov-2018 | $4.06M | 000.00 | Completed | Clinical Trials - General | |
| 12. Grant | 02-Oct-2018 | 000.00 | 000.00 | Completed | Clinical Trials - General | |
| 11. Later Stage VC (Series B) | 30-Nov-2016 | 00.000 | 000.00 | 000.00 | Completed | Clinical Trials - General |
| 10. Grant | 29-Sep-2016 | 000.00 | Completed | Clinical Trials - General | ||
| 9. Later Stage VC (Series B) | 01-Aug-2015 | 00.000 | 000.00 | 000.00 | Completed | Clinical Trials - General |
| 8. Later Stage VC (Series B) | 01-Jun-2014 | 0000 | 000.00 | 0000 | Completed | Clinical Trials - General |
| 7. Later Stage VC | 28-Jun-2013 | 00000 | 000.00 | Completed | Clinical Trials - General | |
| 6. Early Stage VC (Series A2) | 01-May-2012 | 000 | 000.00 | 0000 | Completed | Clinical Trials - General |
| 5. Early Stage VC | 01-Jan-2011 | $2.5M | $7.22M | Completed | Clinical Trials - General | |
| 4. Early Stage VC (Series A1) | 01-Dec-2010 | $2.1M | $4.72M | 00.000 | Completed | Clinical Trials - General |
Cogrx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A2 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A1 | 3,970,776 | $0.001000 | 8% | $0.69 | $0.69 | 1x | $0.69 | 9.86% |
| Series A | 3,067,519 | $0.001000 | 8% | $0.69 | $0.69 | 1x | $0.69 | 7.62% |
Cogrx Competitors (63)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rodin Therapeutics | Formerly VC-backed | Cambridge, MA | 000.00 | 000000&0 | 000.00 | |
| 000000 00000000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | La Jolla, CA | 00000 | 00000000000 | 00000 | |
| 0000000000 | Formerly VC-backed | Cambridge, MA | 00 | 0000 | 000000&0 | 0000 |
| 0000000 0000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 0000000000 | 00000 |
Cogrx Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Audrey's Kitchen | Family Office | 000 0000 | 000000 0 | |||
| Next Act Fund | Angel Group | 000 0000 | 000000 0 | |||
| National Institute On Aging | Government | 000 0000 | 000000 0 | |||
| Steelhead Capital Management | Family Office | Minority | 000 0000 | 000000 0 | ||
| Michael J. Fox Foundation | Limited Partner | 000 0000 | 000000 0 |
Cogrx Executive Team (7)
1 Former Executive
You’re viewing 5 of 7 executives. Get the full list »Cogrx Board Members (12)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Aaron Fletcher Ph.D | Bios Partners | Board Member | 000 0000 | |
| Irwin Scher MD | Self | Board Member | 000 0000 | |
| Kenneth Moch | Cogrx | President, Chief Executive Officer & Board Member | 000 0000 | |
| Mark Breedlove | Self | Board Member | 000 0000 | |
| Peggy Wallace | Golden Seeds | Board Member | 000 0000 |
4 Former Board Members
You’re viewing 5 of 12 board members. Get the full list »